Human Metabolic Flexibility: Its Role in Energy Regulation and Obesity
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Singapore, Singapore, 117599
- Clinical Nutrition Research Centre
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Chinese Male or Female
- Age between 21-35 years
- Body mass index 17.5-32.0 kg/m2
Exclusion Criteria:
- People with major chronic disease such as heart disease, cancer or diabetes mellitus
- People with family history of diabetes
- People who have intolerances or allergies to study foods
- Individuals who are taking drugs known to affect glucose metabolism, body fat distribution, appetite, food intake or energy metabolism
- Individuals who are on a special diet or recently on a weight-lost diet
- Pregnant women
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Low Protein Diet
All subjects will be given a low protein/protein-free diet in order to deplete the label protein pool.
The diet provided will meet the daily energy requirements of all the subjects.
|
Low protein/protein-free diet for 3 days (Day 1, 2 and Day 3) in order to deplete the label protein pool.
The diet provided will meet the daily energy requirements of all the subjects.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight
Time Frame: Day 1
|
Kg
|
Day 1
|
|
Waist Circumference
Time Frame: Day 1
|
cm
|
Day 1
|
|
Hip Circumference
Time Frame: Day 1
|
cm
|
Day 1
|
|
Body fat
Time Frame: Day 1
|
Percentage
|
Day 1
|
|
Estimated visceral adipose tissue area
Time Frame: Day 1
|
cm2
|
Day 1
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Height
Time Frame: Day 1
|
cm
|
Day 1
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2014/01182
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.